Last reviewed · How we verify

thoracic epidural analgesia

Volgograd State Medical University · FDA-approved active Small molecule ✓ Verified May 2026

thoracic epidural analgesia is a Small molecule drug developed by Volgograd State Medical University. It is currently FDA-approved for Perioperative pain management in thoracic surgery, Perioperative pain management in upper abdominal surgery, Chronic pain conditions of the thorax and upper abdomen. Also known as: Thoracic Epidural Anesthesia, TEA, Thoracic Epidural.

Thoracic epidural analgesia delivers local anesthetic and/or opioid medications into the epidural space of the thoracic spine to block pain signals from the chest and upper abdomen.

Thoracic epidural analgesia is a medical intervention that involves injecting a small molecule, such as ropivicaine or fentanyl, into the thoracic epidural space to manage pain, particularly postoperative pain and acute pain. This intervention has been studied in various clinical trials for conditions including postoperative complications, pain, and pectus excavatum, and has been used in conjunction with other interventions like cryoanalgesia and ultrasound.

At a glance

Generic namethoracic epidural analgesia
Also known asThoracic Epidural Anesthesia, TEA, Thoracic Epidural
SponsorVolgograd State Medical University
ModalitySmall molecule
Therapeutic areaPain Management / Anesthesia
PhaseFDA-approved

Mechanism of action

This is a regional anesthesia technique rather than a systemically administered drug. Medications injected into the thoracic epidural space diffuse across the dura mater to block nerve roots and spinal cord segments, providing localized pain relief without the systemic effects of general anesthesia or high-dose systemic opioids. It is commonly used for perioperative pain management in thoracic and upper abdominal surgeries.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about thoracic epidural analgesia

What is thoracic epidural analgesia?

thoracic epidural analgesia is a Small molecule drug developed by Volgograd State Medical University, indicated for Perioperative pain management in thoracic surgery, Perioperative pain management in upper abdominal surgery, Chronic pain conditions of the thorax and upper abdomen.

How does thoracic epidural analgesia work?

Thoracic epidural analgesia delivers local anesthetic and/or opioid medications into the epidural space of the thoracic spine to block pain signals from the chest and upper abdomen.

What is thoracic epidural analgesia used for?

thoracic epidural analgesia is indicated for Perioperative pain management in thoracic surgery, Perioperative pain management in upper abdominal surgery, Chronic pain conditions of the thorax and upper abdomen.

Who makes thoracic epidural analgesia?

thoracic epidural analgesia is developed and marketed by Volgograd State Medical University (see full Volgograd State Medical University pipeline at /company/volgograd-state-medical-university).

Is thoracic epidural analgesia also known as anything else?

thoracic epidural analgesia is also known as Thoracic Epidural Anesthesia, TEA, Thoracic Epidural.

What development phase is thoracic epidural analgesia in?

thoracic epidural analgesia is FDA-approved (marketed).

What are the side effects of thoracic epidural analgesia?

Common side effects of thoracic epidural analgesia include Hypotension, Urinary retention, Pruritus, Nausea, Epidural hematoma (rare), Epidural abscess (rare).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing